Cognition | Mini-Cog |
Significant cognitive impairment is associated with reduced overall survival. Impacts informed consent to treatment. Increased risk of treatment toxicity. Impacts treatment adherence. Impacts communication between patient and healthcare provider.
|
Mood-Depression | Patient Health Questionnaire-9 |
May impact treatment adherence. Impacts quality of life. May impact informed consent to treatment. Screen for suicidal ideation required.
|
Medication use | Brown bag medication review |
Increased risk of drug-drug interactions and other adverse drug events. Increased risk of hospitalisation. Increased risk of treatment toxicity. May impact treatment adherence.
|
Nutritional status | Weight and appetite, serum albumin level |
May impact cancer survival. Increased risk of complications of treatment (surgical wound infection, delirium, pressure ulcers). Malnutrition impacts drug metabolism. Malnutrition impacts functional status and fall risk.
|
Comorbidities | Charlson Comorbidity Index |
May impact survival and cancer treatment goals. Impacts treatment choices in terms of risk of complications. Increased potential for adverse drug events. May impact ability to adhere to cancer treatments and appointments.
|
Functional status | Older American Resources and Services Questionnaire of Instrumental Activities of Daily Living and Grip strength |
Increased risk of treatment toxicity. May impact ability to adhere to cancer treatments and appointments. Increased risk of falls. May need increased support during cancer treatment.
|
Fall risk | Short Physical Performance Battery and self-reported falls question from Cancer and Ageing Treatment Toxicity Risk Tool |
May impact ability to adhere to cancer treatments and appointments. Risk of falls may increase during cancer treatment due to fatigue, dizziness, weakness and dehydration. Impacts quality of life. Falls may become more injurious (bleeding risk and fracture risk). May need rehab/OT/PT to remain at home and independent during and after treatment.
|
Sensory function | Self-reported vision and hearing |
Impacts communication between patient and provider. May impact adherence to treatment and appointments. May impact choice of treatment and treatment toxicity risk.
|
Social support | Self-reported support |
|